
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Cognizant, in its collaboration with TransCelerate BioPharma Inc.-a non-profit organization containing members of global biopharmaceutical companies-announced its new Shared Investigator Platform (SIP) for clinical trial researchers. The platform is cloud-based and will help researchers access, share, and anayze data for the biopharmaceutical industry.
Read the full release






